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Mostpublichealth research on infectious disease and
environmentalchemical risks haspaidlittle attention to
inheritedvariation in susceptibility amongpeople.
The Genomic Era: A Crucial Role for
the Public Health Sciences
With the publication of the complete genomes of the yeast Ifgene expression in micr4
Saccharomyces cerevisiae (1), the worm Caenorhabditis elegans (2), and ray assays and protein express
the fruitfly Drosophila melanogaster (3) and the expected completion in proteomic studies can be a
of a substantially complete human genome sequence (4), scientists lyzed into well-differentiatedI
everywhere can turn their attention to understanding the significance terns, such research will lead
of genetic variation within our species and across species. The vastly improved capabilities
NIEHS anticipated this period with the initiation in 1998 of the address questions about low-lI
Environmental Genome Project (5), which focuses on identification exposures. Such exposures toi
ofallelicvariants (primarily single-nucleotide polymorphisms) ofsus- among the most controversial
ceptibility genes for environmentally related diseases and population- tal health and risk assessmen
based studies of gene-environment interactions. Salient genes curve far downward to lowerc
include those for xenobiotic metabolism and detoxification, hor- studies will be very important.
mone metabolism, receptors, DNA repair, cell cycle, cell death, ray and proteomics results inr
immune and inflammatory responses, nutritional pathways, oxida- become feasible in test animals
tive processes, and signal transduction systems. tings. Additional risk modifie
The concepts and methods ofphysiology, biostatistics and bioin- aging, sex, hormonal and circa(
formatics, epidemiology and population-based prevention trials, and alcohol can be incorporate
environmental and occupational health, and health behavior research The marriage of genetics
are essential for interpreting the coming avalanche of data about golden age for the public heal
genetic variation among people in health and disease (6-8). To particularly for environmental
understand the functions ofgenes and the significance ofvariation in predispositions to disease as i
patterns of thousands ofgenes, researchers need to learn how those ways to modify the gene expr
genes and their gene products interact with exposures to various interact to influence the risk an
environmental chemical, physical, and infectious agents and with conduct ofstudies to determir
metabolic, nutritional, and behavioral factors, as well as with other much in the public interest.
genes (9. These ecogenetic interactions will be incorporated into Empowered by databases
databases through the process now called annotation (10). and gene functions, researchers
More knowledge is needed about the heterogeneity of genetic ages to databases that specify v
predispositions, environmental exposures, and disease risks. al exposures, smoking behavio
Unfortunately, in most public health research on infectious disease nutraceutical use, and medica
and environmental chemical risks, little attention has been given to services for people in defined f
inherited variation in susceptibility among people; the focus has been cohorts of exposed populatioi
only on the agents. Heterogeneity of subpopulations also has been exposures. It is possible that su
neglected in epidemiologic studies in order to generate sufficient lated in a single population
numbers to justify the analysis statistically. For quantitative traits, Nutrition Examination Surve
pharmacologists, toxicologists, and psychologists routinely emphasize air pollution, work site, hospit
means and standard errors of the means, disregarding potentially data would still be necessary tc
informative individuals with extreme responses. Nevertheless, genet- guide predictions ofclinical o0
ics is now at the core ofresearch on cancers, coronary heart disease, tal health risks for people in ti
high blood pressure, neurologic and psychiatric disorders, and a host versity-based studies need to t
of other common dinical conditions, many influenced by environ- research project grants to coi
mental exposures. Properly conducted population studies are crucial agreement or a center grantwil
to demonstrate the significance ofenvironmental exposures to health One crucial barrier could I
risks by showing that technologic or behavioral reductions in levels U.S. Congress and in many,,
ofexposure will lead to a reduction in disease incidence overall, or in individual privacy and the co
particular subpopulations. We can be confident that modern genet- may block the large populatio
ics-enhanced by genomics, proteomics, and bioinformatics-will from patients, families, con
contribute to a scientificallysound strategy for improving health and improving medical care and pi
preventingdisease, the overarching mission ofpublic health. sive bill, originallyintroduced;
oar-
sion
ana-
i to
Sto.
level
ionizing radiation and to chemicals are
and uncertain aspects of environmen-
it(11). Extending the dose-response
doses in toxicologic and epidemiologic
Cross-species comparisons ofmicroar-
response to environmental hazards will
sand in people exposed in various set-
:rs from diet, concomitant exposures,
dian cycles, pharmaceuticals, smoking,
d in these detailed investigations.
and public health should usher in a
Ith sciences and public health practice,
health. No longer do we view genetic
immutable causes of disease; we seek
ression or the many other factors that
nd severity ofthe disease (8). Thus, the
ne these interactions and effects is very
with useful information about genes
in the genomic era will establish link-
;arious environmental and occupation-
r, dietary intakes, pharmaceutical and
and public health interventions and
populations. Such studies require large bns with much improved measures of
bstantial information may be accumu-
study, like the National Health and
y (NHANES) IV. However, links to
tal discharge, and many other kinds of o conduct a comprehensive analysis to
utcomes for patients and environmen-
he community. More often, large uni-
be collaborations, funded by multiple
nsortia members or by a cooperative
thsubcontracts.
paralyze such studies: proposals in the
state legislatures aimed at protecting znfidentiality ofmedical information
)n studies needed to answer questions
nmunities, and policymakers about
ublic health protection. A comprehen-
as "The Genetic PrivacyAct of1995,"
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lays out complex procedures for informed consent, review, and man-
agement of private records to permit research, especially clinical
research with the patient and dose relatives. In this bill, the informa-
tion in one's genetic code is characterized as a "coded probabilistic
future diary because it describes an important part ofa unique and
personal future" (12). Its consent-based provisions for individuals
may be impractical for population studies involving previously col-
lected data on thousands ofpeople. Other legislative proposals which
focus primarily on genetic testing and care of individual patients
mandate that all identifiers, both name and numbers, be removed
from the records (personal medical records).
Another comprehensive effort was the 1999 Report from the
Michigan Governor's Commission on Genetic Privacy and Progress
(13). Even though the mandate did not indude research, the com-
mission proposed that researchers have access to identifiable patient
information for approved studies. Law and ethics are always seeking
a balance between competing social demands, in this case demands
for privacy and for scientific advances. Progress in human genetics,
genetic epidemiology, and ecogenetics requires genetic linkage and
association studies. Such studies cannot be conducted with anony-
mous databases. It is feasible for scientists to keep study information
confidential and to destroy all identifying links (but not the primary
data) once a particular study is concluded. To protect privacy, legis-
lation can be crafted to allow the research, and still protect informa-
tion about specific participants from discovery by third parties.
Legislation could authorize analogues of the Certificates of
Confidentiality issued by the federal government for alcohol and
substance abuse studies. These certificates protect the research data
from discovery, even in civil orcriminal litigation.
Responsibilities and accountability procedures can be specified so
that privacy and confidentiality are protected, and carefillly approved
and carefully monitored access to individual-level records can be
assuredforecogenetics studies thatlinkdataaboutmultiple interacting
risk factors. No area ofthe Human Genome Project needs such a bal-
anced process more than theEnvironmental Genome Project.
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